1. Home
  2. RVMD

RVMD

Revolution Medicines Inc.

Logo Revolution Medicines Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Founded: 2014 Country:
United States
United States
Employees: N/A City: REDWOOD CITY
Market Cap: 5.0B IPO Year: 2020
Target Price: $41.64 AVG Volume (30 days): 1.4M
Analyst Decision: Strong Buy Number of Analysts: 11
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -3.86 EPS Growth: N/A
52 Week Low/High: $15.44 - $38.73 Next Earning Date: 05-06-2024
Revenue: $11,580,000 Revenue Growth: -67.27%
Revenue Growth (this year): -41.59% Revenue Growth (next year): -16.40%

Share on Social Networks: